L9 BioScience

L9 BioScience is a private Canadian life sciences company based in Surrey, British Columbia, with a U.S. affiliate in Wyoming. Publicly available descriptions indicate the company is focused on drug reformulation and delivery technologies intended to improve bioavailability, reduce side effects, and extend the commercial life of existing therapeutics rather than advancing a disclosed clinical-stage proprietary pipeline. The company has appeared in multiple Life Sciences BC investor-readiness and showcase programs, suggesting it is an early-stage venture seeking financing and strategic partners. Very limited primary company disclosures are publicly accessible, so details on specific assets, targets, and indications remain largely undisclosed.